Kar, M. Et Al. 2022. Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment.. European review for medical and pharmacological sciences , vol.26, no.2 Suppl , 65-71.

Kar, M., Ince, I., Yildirim, C., Burukoğlu Dönmez, D., Karasulu, Y., & Cingi, C., (2022). Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment.. European review for medical and pharmacological sciences , vol.26, no.2 Suppl, 65-71.

Kar, M Et Al. "Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment.," European review for medical and pharmacological sciences , vol.26, no.2 Suppl, 65-71, 2022

Kar, M Et Al. "Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment.." European review for medical and pharmacological sciences , vol.26, no.2 Suppl, pp.65-71, 2022

Kar, M. Et Al. (2022) . "Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment.." European review for medical and pharmacological sciences , vol.26, no.2 Suppl, pp.65-71.

@article{article, author={M Kar Et Al. }, title={Development of an intranasal formulation containing indomethacin and xylometazoline for rhinosinusitis treatment.}, journal={European review for medical and pharmacological sciences}, year=2022, pages={65-71} }